Save the Date: International Pediatric Neuro-Oncology meeting/Florida Brain Tumor Summit, March 16

Forgot Password?

The International Pediatric Neuro-Oncology meeting/Florida Brain Tumor Summit will be held in Orlando March 16 - 18, 2017. Please mark your calendars. It begins with a reception on the evening of March 16, 2017, with scientific sessions to be held March 17-18, 2017 in Orlando, Florida. Please let your colleagues know as well!

Speakers will provide the latest information about multiple immunotherapeutic strategies aimed at malignant brain tumors, immune gene therapy trials, genetically engineered poliovirus treatment, other oncolytic virus strategies, EBV-specific T cells and chimeric antigen receptor T cells, and updates on transplant strategies (to name a few topics).

Meeting Co-Directors have selected an outstanding group of international experts, including Stephen Gottschalk (Baylor – Antigen specific T cell therapy), Michael Platten (University of Heidelberg, Germany – Vaccines targeting IDH1 mutation in glioma), Jonathan Finlay (National Children’s Hospital – Transplant), Matthias Gromier (Duke – Genetically engineered poliovirus as an anti-cancer agent) and Duane Mitchell (University of Florida – Cellular immunotherapy for pediatric and adult brain cancer).

This is an unprecedented opportunity for brain cancer researchers and clinicians to meet the experts and discuss issues with them – all in our Florida back yard.

Please make plans to attend. Click here to view the brochure, which contains the agenda and registration information. We are also soliciting abstracts for poster sessions. Please let me know if you have questions.

Barbara Frentzen, ARNP, MSN
Administrative Director, Florida Center for Brain Tumor Research
Department of Neurosurgery, P.O. Box 100265, Gainesville, FL 32610-0265
(352) 294-0517 This email address is being protected from spambots. You need JavaScript enabled to view it.

The information and content provided on this website is made available for informational purposes only for children and their families affected by cancer. While the Children's Oncology Group strives to provide accurate and up-to-date information, the information may be out of date or incomplete in certain respects. Please do not rely on this information and seek the care of a qualified medical professional if you have questions regarding a specific medical condition, disease, diagnosis or symptom. The information and content presented herein is not intended to replace the independent clinical judgement, medical advice, screening, health counseling, or other intervention performed by your (or your child's) health care provider. Please contact "911" or your emergency services if this is a health emergency. No endorsement of any specific tests, products, or procedures is made herein.